Fig. 2From: Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease Cumulative incidence of MACE across quintiles of the risk score in the AÂ derivation (TECOS) and BÂ validation (ACCORD) cohorts. MACE is a composite of first nonfatal myocardial infarction, nonfatal stroke, or cardiovascular deathBack to article page